INVIVYD, INC. Basic Shares Outstanding (Weighted Average)
INVIVYD, INC. (IVVD) reported Basic Shares Outstanding (Weighted Average) of 320.44 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-13
- INVIVYD, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 320.44M shares, a 166.99% increase year-over-year.
- INVIVYD, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 309.67M shares, a 158.31% increase year-over-year.
- INVIVYD, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 278.23M shares, a 132.38% increase year-over-year.
- INVIVYD, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 170.17M shares, a 42.41% increase year-over-year.
- INVIVYD, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 172.21M shares, a 45.26% increase from fiscal 2024.
- INVIVYD, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 118.56M shares, a 8.24% increase from fiscal 2023.
- INVIVYD, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 109.53M shares, a 1.16% increase from fiscal 2022.
- INVIVYD, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 108.27M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 7 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | 320.44M shares 10-Q · filed 2026-08-13 | 315.08M shares 10-Q · filed 2026-08-13 | 302.78M shares derived: average of 3 quarters · filed 2026-08-13 | 269.63M shares derived: average of 4 quarters · filed 2026-08-13 | |
| 2026-03-31 | 309.67M shares 10-Q · filed 2026-05-14 | 293.95M shares derived: average of 2 quarters · filed 2026-05-14 | 252.69M shares derived: average of 3 quarters · filed 2026-05-14 | 219.52M shares derived: average of 4 quarters · filed 2026-08-13 | |
| 2025-12-31 | 278.23M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | 224.20M shares derived: average of 2 quarters · filed 2026-03-05 | 189.47M shares derived: average of 3 quarters · filed 2026-08-13 | 172.21M shares 10-K · filed 2026-03-05 | |
| 2025-09-30 | 170.17M shares 10-Q · filed 2025-11-06 | 145.09M shares derived: average of 2 quarters · filed 2026-08-13 | 136.87M shares 10-Q · filed 2025-11-06 | 132.45M shares derived: average of 4 quarters · filed 2026-08-13 | |
| 2025-06-30 | 120.02M shares 10-Q · filed 2026-08-13 | 119.95M shares 10-Q · filed 2026-08-13 | 119.88M shares derived: average of 3 quarters · filed 2026-08-13 | 119.78M shares derived: average of 4 quarters · filed 2026-08-13 | |
| 2025-03-31 | 119.88M shares 10-Q · filed 2026-05-14 | 119.81M shares derived: average of 2 quarters · filed 2026-05-14 | 119.70M shares derived: average of 3 quarters · filed 2026-05-14 | 119.62M shares derived: average of 4 quarters · filed 2026-05-14 | |
| 2024-12-31 | 119.73M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | 119.61M shares derived: average of 2 quarters · filed 2026-03-05 | 119.53M shares derived: average of 3 quarters · filed 2026-03-05 | 118.56M shares 10-K · filed 2026-03-05 | |
| 2024-09-30 | 119.50M shares 10-Q · filed 2025-11-06 | 119.43M shares derived: average of 2 quarters · filed 2025-11-06 | 118.16M shares 10-Q · filed 2025-11-06 | 116.14M shares derived: average of 4 quarters · filed 2025-11-06 | |
| 2024-06-30 | 119.36M shares 10-Q · filed 2025-08-14 | 117.49M shares 10-Q · filed 2025-08-14 | 115.03M shares derived: average of 3 quarters · filed 2025-08-14 | 113.71M shares derived: average of 4 quarters · filed 2025-08-14 | |
| 2024-03-31 | 115.62M shares 10-Q · filed 2025-05-15 | 112.86M shares derived: average of 2 quarters · filed 2025-05-15 | 111.83M shares derived: average of 3 quarters · filed 2025-05-15 | 111.23M shares derived: average of 4 quarters · filed 2025-05-15 | |
| 2023-12-31 | 110.10M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | 109.93M shares derived: average of 2 quarters · filed 2025-03-20 | 109.77M shares derived: average of 3 quarters · filed 2025-03-20 | 109.53M shares 10-K · filed 2025-03-20 | |
| 2023-09-30 | 109.75M shares 10-Q · filed 2024-11-14 | 109.60M shares derived: average of 2 quarters · filed 2024-11-14 | 109.33M shares 10-Q · filed 2024-11-14 | 109.15M shares derived: average of 4 quarters · filed 2024-11-14 | |
| 2023-06-30 | 109.45M shares 10-Q · filed 2024-08-14 | 109.12M shares 10-Q · filed 2024-08-14 | 108.95M shares derived: average of 3 quarters · filed 2024-08-14 | 108.82M shares derived: average of 4 quarters · filed 2024-08-14 | |
| 2023-03-31 | 108.79M shares 10-Q · filed 2024-05-09 | 108.70M shares derived: average of 2 quarters · filed 2024-05-09 | 108.61M shares derived: average of 3 quarters · filed 2024-05-09 | 108.50M shares derived: average of 4 quarters · filed 2024-05-09 | |
| 2022-12-31 | 108.61M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | 108.52M shares derived: average of 2 quarters · filed 2024-03-28 | 108.40M shares derived: average of 3 quarters · filed 2024-03-28 | 108.27M shares 10-K · filed 2024-03-28 | |
| 2022-09-30 | 108.42M shares 10-Q · filed 2023-11-09 | 108.29M shares derived: average of 2 quarters · filed 2023-11-09 | 108.15M shares 10-Q · filed 2023-11-09 | 108.48M shares derived: average of 4 quarters · filed 2024-02-09 | |
| 2022-06-30 | 108.17M shares 10-Q · filed 2023-08-10 | 108.02M shares 10-Q · filed 2023-08-10 | 108.49M shares derived: average of 3 quarters · filed 2024-02-09 | 96.69M shares derived: average of 4 quarters · filed 2024-02-09 | |
| 2022-03-31 | 107.87M shares 10-Q · filed 2023-05-11 | 108.66M shares derived: average of 2 quarters · filed 2024-02-09 | 92.87M shares derived: average of 3 quarters · filed 2024-02-09 | 69.72M shares derived: average of 4 quarters · filed 2024-02-09 | |
| 2021-12-31 | 109.44M shares derived: 8-K 12 month − 10-Q 9 month · filed 2024-02-09 | 85.37M shares derived: average of 2 quarters · filed 2024-02-09 | 57.00M shares derived: average of 3 quarters · filed 2024-02-09 | 42.62M shares 8-K · filed 2024-02-09 | |
| 2021-09-30 | 61.30M shares 10-Q · filed 2022-11-10 | 30.77M shares derived: average of 2 quarters · filed 2022-11-10 | 20.35M shares 10-Q · filed 2022-11-10 | ||
| 2021-06-30 | 249.77K shares 10-Q · filed 2022-08-15 | 125.57K shares 10-Q · filed 2022-08-15 | |||
| 2021-03-31 | 0.00 shares 10-Q · filed 2022-05-13 | ||||
| 2020-12-31 | 3.61M shares 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |